Clinical Trials

203 enrolled 22 charts

Phase 3 Not yet recruiting

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06914011 2025-12-03

MRD2START

172 enrolled

Esophageal Neoplasms

NCT04540211 2025-10-28

SKYSCRAPER-08

461 enrolled

Esophageal Neoplasms

NCT05357846 2025-06-12

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Phase 3 Recruiting

422 enrolled

Phase 3 Active not recruiting

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02509286 2024-05-08

ESOPEC

438 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT03933449 2023-03-29

KEYNOTE-181

123 enrolled 25 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT02564263 2023-03-13

KEYNOTE-181

628 enrolled 27 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT01726452 2022-09-30

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

377 enrolled

Esophageal Neoplasms

NCT02569242 2022-07-06

Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer

419 enrolled 20 charts 2 FDA

Esophageal Neoplasms

NCT05188313 2022-06-24

TRAP-2

Phase 3 Recruiting

376 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00655876 2022-06-14

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

344 enrolled 11 charts

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04426955 2021-09-16

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

396 enrolled

Esophageal Neoplasms

NCT03308552 2019-01-02

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

164 enrolled

Esophageal Neoplasms

NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

Phase 3 Recruiting

300 enrolled

Esophageal Neoplasms, Recurrence

NCT03366883 2018-01-09

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

420 enrolled

Esophageal Neoplasms

NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

486 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

NCT02570893 2015-10-07

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

366 enrolled

Esophageal Neoplasms

NCT00686114 2014-04-29

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

344 enrolled